Even though inherited point mutations in PAX5 have been reported to result in increased leukemia incidence [104], the reduced functional TF activity more commonly depends on the inactivation of the TF genes via somatic heterozygote mutations and deletions [94,95,96]. This evidence concerns the gene TF and leukemia.